Marshall Wace’s iRadimed IRMD Stock Holding History

Marshall Wace’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.42M	Buy	+25,298	New	+$2.3M	﹤0.01%	1751
2024 Q3	–	Sell	-10,531	Closed	-$463K	–	2730
2024 Q2	$463K	Buy	+10,531	New	+$448K	﹤0.01%	1993
2022 Q2	–	Sell	-5,459	Closed	-$246K	–	3642
2022 Q1	$246K	Sell	5,459 -29,121	-84%	-$1.35M	﹤0.01%	3023
2021 Q4	$1.6M	Buy	+34,580	New	+$1.4M	﹤0.01%	2187
2020 Q2	–	Sell	-37,904	Closed	-$809K	–	1749
2020 Q1	$809K	Sell	37,904 -28,318	-43%	-$674K	0.01%	855
2019 Q4	$1.55M	Sell	66,222 -36,336	-35%	-$849K	0.01%	875
2019 Q3	$2.16M	Buy	102,558 +28,142	+38%	+$574K	0.02%	745
2019 Q2	$1.52M	Buy	74,416 +65,819	+766%	+$1.55M	0.01%	845
2019 Q1	$241K	Buy	+8,597	New	+$225K	﹤0.01%	1304

Other funds holding IRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Marshall Wace's IRMD Position: Q2 2026 in Review

Marshall Wace opened a new position in iRadimed (IRMD) in Q2 2026: 25,298 shares worth $2.42M. The stake represents ﹤0.01% of the portfolio and ranks #1751 among its holdings. This is a return to the name: Marshall Wace previously reported a position in IRMD as recently as Q2 2024.

Marshall Wace first reported a position in IRMD in Q1 2019 and has held it in 9 quarters since. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

Marshall Wace held 25,298 shares of iRadimed worth $2.42M as of Q2 2026.
iRadimed was a new Marshall Wace position in Q2 2026.
iRadimed made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #1751 holding.
Marshall Wace first reported a position in iRadimed in Q1 2019 and has held it in 9 quarters since.
214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.